Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Insamo is transforming drug discovery for challenging diseases through its automated platform that designs, synthesizes, and tests cyclic-peptides at an unprecedented scale. By leveraging trillions…

Insamo is transforming drug discovery for challenging diseases through its automated platform that designs, synthesizes, and tests cyclic-peptides at an unprecedented scale. By leveraging trillions…
Founded: 2022
Headquarters: Berkeley, California
Focus: Automated discovery of membrane-permeable, orally available cyclic peptides
Tech/Product: Automated design, synthesis, and testing platform for cyclic peptides
Recent financing: Seed / non-equity assistance event April 2024
Drug discovery for challenging targets using peptide therapeutics, specifically membrane-permeable and orally available cyclic peptides.
2022
Biotechnology
Non-equity assistance event closed April 2, 2024
“Participation from institutional and life-science investors including Playground Global, venBio Partners, Intel Ignite, BEVC, Axial VC and others”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,400+
New This Week